Ligand Complexes Generated during Cytochrome P-450 Dependent Metabolism

  • Michael R. Franklin
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

The characterization and quantitation of cytochrome P-450 as it is known to much of the scientific community, depends not on its enzymic activity, but on the interaction of the heme iron with a ligand (Omura and Sato 1964).

Keywords

Ligand Complex Allyl Alcohol Hepatic Microsome Metha None Piperonyl Butoxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baron, J., Redick, J. A. and Guengerich, F. P., 1978, “Immunohistochemical Localizations of Cytochromes P-450 in Rat Liver.” Life Sci., 23: 2627.PubMedCrossRefGoogle Scholar
  2. Buening, M. K. and Franklin, M. R., 1974, “The Formation of Complexes Absorbing at 455 nm From Cytochrome P-450 and Metabolites of Compounds Related to SKF 525-A.” Drug Metab. Disp. 2: 386.Google Scholar
  3. Buening, M. K. and Franklin, M. R., 1976, “SKF 525-A Inhibition, Induction, and 452-nm Complex Formation.” Drug Metab. Disp. 4: 244.Google Scholar
  4. Elcombe, C. R., Bridges, J., Nimmo-Smith, R. H. and Werringloer, J., 1975, “Cumene Hydroperoxide-Mediated Formation of Inhibited Complexes of Methylenedioxyphenyl Compounds with Cytochrome P-450. Biochem. Soc. Trans., 3: 967.Google Scholar
  5. Elcombe, C. R., Dickens, M., Sweatman, B. and Bridges, J. W., 1976, “Substrate-Elicited Dissociation of the Isosafrole Metabolite-Cytochrome P-450 Complex and the Consequential Reactivation of Monooxygenation.” in: “Microsomes and Drug Oxidations,” Ullrich, Roots, Hildebrandt, Estabrook and Conney, eds., Pergamon Press, p. 247.Google Scholar
  6. Franklin, M. R., 1974, “The Influence of Cytochrome P-450 Induction on the Metabolic Formation of 455-nm Complexes From Amphetamines.” Drug Metab. Disp., 2: 321.Google Scholar
  7. Franklin, M. R., 1974, “The Formation of a 455 nm Complex During Cytochrome P-450-Dependent N-Hydroxyamphetamine Metabolism.” Mol. Pharmacol., 10: 975.Google Scholar
  8. Franklin, M. R.,,1976, “A New Class of Inhibitory Cytochrome P-450 Complexes Formed During Metabolism: A Comparison With Amphetamine and SKF 525-A Type Complexes.” Chem. Biol. Interactions, 14: 337.Google Scholar
  9. Franklin, M. R., 1977, “Inhibition of Mixed-Function Oxidations by Substrates Forming Reduced Cytochrome P-450 Metabolic- Intermediate Cômplexes.” Pharmacology and Therapeutics, 2: 227.Google Scholar
  10. Franklin, M. R., Wolf, C. R., Serabjit-Singh, C. and Philpot, R. M., 1980, “Quantitation of Two Forms of Pulmonary Cytochrome P-450 in Microsomes, Using Substrate Specificities.” Mol. Pharmacol., 17: 415.PubMedGoogle Scholar
  11. Gooding, P. E., Chayen, J., Sawyer, B. and Slater, T. F., 1978, “Cytochrome P-450 Distribution in Rat Liver and the Effect of Sodium Phenobarbitone Administration.” Chem. Biol. Interactions, 20: 299.CrossRefGoogle Scholar
  12. Hildebrandt, A. G., Leibman, K. C. and Estabrook, R. W., 1969, “Metyrapone Interaction with Hepatic Microsomal Cytochrome P-450 from Rats Treated with Phenobarbital.” Biochem. Biophys. Res. Commun., 37: 477.PubMedCrossRefGoogle Scholar
  13. Luu-The, V., Gumps, J. and Dumont, P., 1980, “Metyrapone-Reduced Cytochrome P-450 Complex: A Specific Method for the Determination of the Phenobarbital Inducible Form of Rat Hepatic Microsomal Cytochrome P-450.” Biochem. Biophys. Res. Commun., 93: 776.PubMedCrossRefGoogle Scholar
  14. Mansuy, D., Gans, P., Chottard, J. and Bartoli, J., 1977,“Nitrosoalkanes as Fe(II) Ligands in the 455-nm-Absorbing Cytochrome P-450 Complexes Formed from Nitroalkanes in Reducing Conditions.” Eur. J. Biochem., 76: 607.Google Scholar
  15. Omura, T. and Sato, R., 1964, “The Carbon Monoxide-binding Pigment of Liver Microsomes.” J. Biol. Chem., 239: 2370.PubMedGoogle Scholar
  16. Philpot, R. M. and Hodgson, E., 1971, “The Production and Modification of Cytochrome P-450 Difference Spectra by In Vivo Administration of Methylenedioxyphenyl Compounds.” Chem. Biol. Interactions, 4: 185.CrossRefGoogle Scholar
  17. Reid, W. D., 1972, “Mechanism of Allyl Alchol-Induced Hepatic Necrosis.” Experientia, 28: 1058.PubMedCrossRefGoogle Scholar
  18. Reid, W. D. and Krishna, G., 1973, “Centrolobular Hepatic Necrosis Related to Covalent Binding of Metabolites of Halogenated Aromatic Hydrocarbons.” Exp. Molec. Path., 18: 80.PubMedCrossRefGoogle Scholar
  19. Ullrich, V., Nastainczyk, W. and Ruf, H. H., 1975, “Ligand Reactions of Cytochrome P-450.” Biochem. Soc. Trans., 3: 803.Google Scholar
  20. Werringloer, J. and Estabrook, R. W., 1975, “Heterogeneity of Liver Microsomal Cytochrome P-450: The Spectral Characterization of Reactants with Reduced Cytochrome P-450.” Arch. Biochem. Biophys., 176: 270.CrossRefGoogle Scholar
  21. Wolf, C. R., Szutowski, M.M., Ball, L. M. and Philpot, R.M., 1978, “The Rabbit Pulmonary Monooxygenase System: Characteristics and Activities of Two Forms of Pulmonary Cytochrome P-450.” ChemoBiol. Interactions, 21: 29.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Michael R. Franklin
    • 1
  1. 1.Department of Biochemical Pharmacology and ToxicologyUniversity of UtahSalt Lake CityUSA

Personalised recommendations